These results strongly suggested that the reduction of H3K9me3 in the promoter region was one of the reasons for the overproduction of CREMα in SLE CD4+ T cells, and the H3K9me3 enrichment at the CREMα promoter could reflect the disease activity of SLE. The gene discussed is CD4; the disease is systemic lupus erythematosus.